Isoket

Isosorbide dinitrate, the active ingredient in Isoket, is a nitrate vasodilator presented as an oromucosal preparation for oromucosal use. It treats angina pectoris and heart failure in adult patients.

GNH USA supplies Isoket as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoket belongs to the nitrate vasodilator class and is used in cardiovascular conditions where reduced myocardial oxygen demand is needed. - Angina pectoris: decreases the frequency and severity of chest pain episodes. - Chronic stable angina: provides prophylactic relief of anginal attacks. - Heart failure: improves exercise tolerance and reduces symptoms of congestive heart failure.

Isoket may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Headache: throbbing pain often occurring shortly after dosing. - Dizziness or light‑headedness: related to blood pressure lowering. - Flushing: warm sensation and reddening of the skin. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Syncope: transient loss of consciousness. - Allergic reaction: rash, itching, or swelling that may indicate hypersensitivity.

Before prescribing Isoket, clinicians should consider several safety measures. - Monitor blood pressure: watch for excessive drops, especially after the first dose. - Avoid concurrent nitrates: combined use can cause profound hypotension. - Caution with phosphodiesterase‑5 inhibitors: risk of severe blood pressure reduction. - Adjust in renal impairment: dose may need modification in patients with reduced kidney function. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Isoket can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Sildenafil, tadalafil, or other PDE‑5 inhibitors: may cause dangerous hypotension. - Other organic nitrates (e.g., nitroglycerin): additive vasodilatory effect. - Nitroprusside: synergistic blood pressure lowering.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (e.g., ACE inhibitors, beta‑blockers): may enhance blood pressure reduction. - Diuretics: can increase the risk of dehydration and hypotension. - Alcohol: may potentiate vasodilatory effects and dizziness.